MENU
+Compare
RCUS
Stock ticker: NYSE
AS OF
Dec 26, 12:02 PM (EDT)
Price
$23.07
Change
-$0.05 (-0.22%)
Capitalization
2.86B

RCUS Arcus Biosciences Forecast, Technical & Fundamental Analysis

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company... Show more

RCUS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for RCUS with price predictions
Dec 24, 2025

RCUS sees MACD Histogram just turned negative

RCUS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on December 09, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 43 instances where the indicator turned negative. In of the 43 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for RCUS moved out of overbought territory on December 09, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on December 11, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RCUS as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCUS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where RCUS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RCUS advanced for three days, in of 271 cases, the price rose further within the following month. The odds of a continued upward trend are .

RCUS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 213 cases where RCUS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RCUS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.562) is normal, around the industry mean (26.541). P/E Ratio (0.000) is within average values for comparable stocks, (51.479). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.873). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (9.699) is also within normal values, averaging (311.015).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCUS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
RCUS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

RCUS is expected to report earnings to fall 11.81% to -112 cents per share on February 25

Arcus Biosciences RCUS Stock Earnings Reports
Q4'25
Est.
$-1.12
Q3'25
Beat
by $0.01
Q2'25
Beat
by $1.12
Q1'25
Missed
by $0.12
Q4'24
Beat
by $0.20
The last earnings report on October 28 showed earnings per share of -126 cents, beating the estimate of -127 cents. With 444.83K shares outstanding, the current market capitalization sits at 2.86B.
A.I. Advisor
published General Information

General Information

a company which offers pre-clinical drug discovery and development solutions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
3928 Point Eden Way
Phone
+1 510 694-6200
Employees
577
Web
https://www.arcusbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LSCRX23.090.07
+0.30%
Loomis Sayles Small Cap Value Retail
FLPKX41.530.09
+0.22%
Fidelity Low-Priced Stock K
TWMTX145.830.27
+0.19%
Transamerica US Growth T
SSIFX23.28N/A
N/A
Saturna International
FITMX18.25-0.01
-0.05%
Fidelity SAI International Mtm Idx

RCUS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with XNCR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
+1.81%
XNCR - RCUS
55%
Loosely correlated
-0.13%
IDYA - RCUS
50%
Loosely correlated
+0.76%
SYRE - RCUS
47%
Loosely correlated
-0.54%
KURA - RCUS
47%
Loosely correlated
+2.50%
TYRA - RCUS
46%
Loosely correlated
+0.81%
More